Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/12950
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBranavan, M-
dc.contributor.authorMackay, RE-
dc.contributor.authorCraw, P-
dc.contributor.authorNaveenathayalan, A-
dc.contributor.authorAhern, JC-
dc.contributor.authorSivanesan, T-
dc.contributor.authorHudson, C-
dc.contributor.authorStead, T-
dc.contributor.authorKremer, J-
dc.contributor.authorGarg, N-
dc.contributor.authorBaker, M-
dc.contributor.authorSadiq, ST-
dc.contributor.authorBalachandran, W-
dc.date.accessioned2016-07-18T10:24:31Z-
dc.date.available2015-04-04-
dc.date.available2016-07-18T10:24:31Z-
dc.date.issued2016-
dc.identifier.citationMedical Engineering and Physics, 38(8): pp. 741–748, (2016)en_US
dc.identifier.issn1350-4533-
dc.identifier.urihttp://www.sciencedirect.com/science/article/pii/S1350453316300789-
dc.identifier.urihttp://bura.brunel.ac.uk/handle/2438/12950-
dc.description.abstractThis paper presents the design of a modular point of care test platform that integrates a proprietary sample collection device directly with a microfluidic cartridge. Cell lysis, within the cartridge, is conducted using a chemical method and nucleic acid purification is done on an activated cellulose membrane. The microfluidic device incorporates passive mixing of the lysis-binding buffers and sample using a serpentine channel. Results have shown extraction efficiencies for this new membrane of 69% and 57% compared to the commercial Qiagen extraction method of 85% and 59.4% for 0.1ng/μL and 100ng/μL salmon sperm DNA respectively spiked in phosphate buffered solution. Extraction experiments using the serpentine passive mixer cartridges incorporating lysis and nucleic acid purification showed extraction efficiency around 80% of the commercial Qiagen kit. Isothermal amplification was conducted using thermophillic helicase dependant amplification and recombinase polymerase amplification. A low cost benchtop real-time isothermal amplification platform has been developed capable of running six amplifications simultaneously. Results show that the platform is capable of detecting 1.32×106 of sample DNA through thermophillic helicase dependant amplification and 1×105 copy numbers Chlamydia trachomatis genomic DNA within 10min through recombinase polymerase nucleic acid amplification tests.en_US
dc.description.sponsorshipThis work is funded under the UKCRC Translational Infection Research (TIR) Initiative supported by the Medical Research Council (Grant number G0901608) with contributions to the grant from the Biotechnology and Biological Sciences Research Council, the National Institute for Health Research on behalf of the Department of Health, the Chief Scientist Office of the Scottish Government Health Directorates and the Wellcome Trust. Axxin are thanked for sup- plying the T16-ISO platform.en_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.subjectMicrofluidicsen_US
dc.subjectMicroengineeringen_US
dc.subjectPoint-of-careen_US
dc.subjectMolecular diagnosticsen_US
dc.titleModular development of a prototype point of care molecular diagnostic platform for sexually transmitted infectionsen_US
dc.typeArticleen_US
dc.identifier.doihttp://dx.doi.org/10.1016/j.medengphy.2016.04.022-
dc.relation.isPartOfMedical Engineering and Physics-
pubs.publication-statusAccepted-
Appears in Collections:Publications

Files in This Item:
File Description SizeFormat 
Fulltext.pdf1.98 MBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.